Published on Nov 6, 2014
New research conducted at UAB has shown that the common blood pressure drug verapamil completely reverses diabetes in animal models. Now, thanks to a three-year, $2.1 million grant from the JDRF, UAB researchers will begin conducting a potentially groundbreaking clinical trial in 2015 to see if it can do the same in humans. Enrollment info and more details here: http://www.uab.edu/news/innovation/item/5508-in-human-clinical-trial-uab-to-test-drug-shown-to-completely-reverse-diabetes-in-human-islets-mice
New research conducted at UAB has shown that the common blood pressure drug verapamil completely reverses diabetes in animal models. Now, thanks to a three-year, $2.1 million grant from the JDRF, UAB researchers will begin conducting a potentially groundbreaking clinical trial in 2015 to see if it can do the same in humans. Enrollment info and more details here: http://www.uab.edu/news/innovation/item/5508-in-human-clinical-trial-uab-to-test-drug-shown-to-completely-reverse-diabetes-in-human-islets-mice
The trial, known as “the repurposing of verapamil as a beta cell survival therapy in type 1 diabetes,” is scheduled to begin early next year and has come to fruition after more than a decade of research efforts in UAB’s Comprehensive Diabetes Center.
Verapamil, a rather common blood pressure medication, has recently reversed diabetes in mice. Thanks to a generous grant from JDRF, University of Alabama-Birmingham researchers will soon begin testing on humans with diabetes, in hopes that they can encounter similar results.
Verapamil, a rather common blood pressure medication, has recently reversed diabetes in mice. Thanks to a generous grant from JDRF, University of Alabama-Birmingham researchers will soon begin testing on humans with diabetes, in hopes that they can encounter similar results.
Courtesy of TheDiabetesSite.com Blog - http://blog.thediabetessite.com/verapamilcuretesting/?utm_source=social%20&utm_medium=dbsaware&utm_campaign=verapamilcuretesting&utm_term=20141112
No comments:
Post a Comment